Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

Healthcare Biotechnology
"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Akela Pharma Inc. > CEO bougth recently...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Biostocks01on Aug 28, 2012 4:07pm
184 Views
Post# 20270988

CEO bougth recently...

CEO bougth recently...

Insider: Transaction:
Date Insider: Shares Transaction Value
08/16/12 Emmelot, Rudy,
Senior Officer of Issuer		 1,000 Acquisition or disposition in the public market at
.06 -
.06 per share.		 $58
08/16/12 Emmelot, Rudy,
Senior Officer of Issuer		 1,000 Acquisition or disposition in the public market at
.06 -
.06 per share.		 $58

i'm agree is not a lot...but he bought during last months

Bio

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities